{
  "docId": "019dd923-5de0-76bd-a169-83187257f35b",
  "docSlug": "5d146414b5cc38c9",
  "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors",
  "authorId": "BCG",
  "authorName": "BCG",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 14,
  "pageCount": 34,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Includes a detailed legend/note section at the bottom regarding data sources and assumptions.",
  "elementsJson": [
    "timeline_visual",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/14",
  "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b",
  "deckJsonHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b.json",
  "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-14",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Current best-case scenario for US points to start of broad distribution in Q2 2021, subject to a set of pre-conditions.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-fefb-728e-ad97-504b83a9dbad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Timeline showing Q4 2020 to End 2021 with pre-conditions and milestones",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1596c7d5-bf7f-4aba-825d-0f87e3fbfea2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "Note: The timeline represented is highly dependent on Phase III vaccine results and hence, subject to change...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d61df4a7-a63b-4b02-b47a-25ae9fa0b323",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.7,
        "y": 0.25
      },
      "kind": "list",
      "text": "50% efficacy threshold; $5.8B allocated; 800M doses pre-booked; McKesson/BD roles; HHS strategy; 40-60% willingness",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe9092e3-2db1-4c0d-a692-3fbeb436d18f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Timeline: Q2 2021",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-fefb-728e-ad97-546d1aff80ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Broad distribution timelines | Current best-case scenario for US points to start of broad distribution in Q2 2021, subject to a set of pre-conditions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0bb8f01-e117-4aba-ba6c-672ab65096fd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Causal Chain",
      "slug": "causal-chain",
      "agent": "Architect",
      "layer": "loop",
      "matchId": "019dd95a-163f-72bd-8a09-34391a721543",
      "evidence": "Pre-conditions cascade leads to milestones (EUA -> sub-segment -> broad -> herd).",
      "confidence": 78
    },
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "019dd95a-163f-72bd-8a09-30185a53cabe",
      "evidence": "Title commits a forecast: broad distribution in Q2 2021.",
      "confidence": 85
    },
    {
      "name": "Visual Hierarchy",
      "slug": "visual-hierarchy",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "019dd95a-163f-72bd-8a09-380c5632ec6b",
      "evidence": "Quarter labels organize 7 stacked pre-condition bars in time.",
      "confidence": 65
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "641142c2-2885-476a-a9e8-6e94a2bafbd9",
      "evidence": "Timeline visualization of tasks and milestones over time",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 17,
      "from": 9,
      "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors",
      "position": 3,
      "confidence": 78,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 14,
      "from": 4,
      "beatId": "019dd95a-0702-74a3-87e3-b9ab3fe072a9",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Snapshot, epidemic curves, vaccine pipeline, timelines",
      "position": 1,
      "confidence": 65,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 9,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "019dd95a-088c-724c-b30f-be0320e082a4",
      "evidence": "p11-12 frame unprecedented response and 12-18 month window; p13-14 detail fast movers and Q2 2021 distribution.",
      "position": 3,
      "objective": "Establish unprecedented vaccine response and timeline opportunity",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 75,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}